Hill SR - Search Results

1

Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.

McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, Macdonald GJ, Day RO, Maguire J, Henderson KM. McNeill PM, et al. Among authors: hill sr. Intern Med J. 2006 Sep;36(9):571-8. doi: 10.1111/j.1445-5994.2006.01151.x. Intern Med J. 2006. PMID: 16911549

2

Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.

Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO. Henry DA, et al. Among authors: hill sr. Med J Aust. 2005 Jun 6;182(11):557-60. doi: 10.5694/j.1326-5377.2005.tb06813.x. Med J Aust. 2005. PMID: 15938681

3

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.

Henry D, Doran E, Kerridge I, Hill S, McNeill PM, Day R. Henry D, et al. Arch Intern Med. 2005 Nov 28;165(21):2493-6. doi: 10.1001/archinte.165.21.2493. Arch Intern Med. 2005. PMID: 16314546

4

Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.

Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K. Kerridge I, et al. Intern Med J. 2005 Apr;35(4):206-10. doi: 10.1111/j.1444-0903.2004.00799.x. Intern Med J. 2005. PMID: 15836497

5

Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.

Henry DA, Hill SR, Harris A. Henry DA, et al. Among authors: hill sr. JAMA. 2005 Nov 23;294(20):2630-2. doi: 10.1001/jama.294.20.2630. JAMA. 2005. PMID: 16304078 No abstract available.

6

Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme.

Hill SR, Mitchell AS, Henry DA. Hill SR, et al. JAMA. 2000 Apr 26;283(16):2116-21. doi: 10.1001/jama.283.16.2116. JAMA. 2000. PMID: 10791503

7

Drug information for consumers: should it be disease or medication specific? Results of a community survey.

Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Newby DA, et al. Among authors: hill sr. Aust N Z J Public Health. 2001 Dec;25(6):564-70. doi: 10.1111/j.1467-842x.2001.tb00327.x. Aust N Z J Public Health. 2001. PMID: 11824997 Free article.

8

Assessing new health technologies: lessons to be learned from drugs.

Henry DA, Hill SR. Henry DA, et al. Among authors: hill sr. Med J Aust. 1999 Nov 15;171(10):554-6. doi: 10.5694/j.1326-5377.1999.tb123795.x. Med J Aust. 1999. PMID: 10816710

9

The effects of information framing on the practices of physicians.

McGettigan P, Sly K, O'Connell D, Hill S, Henry D. McGettigan P, et al. J Gen Intern Med. 1999 Oct;14(10):633-42. doi: 10.1046/j.1525-1497.1999.09038.x. J Gen Intern Med. 1999. PMID: 10571710 Free PMC article. Review.

10

Use of pharmacoeconomics in prescribing research. Part 2: cost-minimization analysis--when are two therapies equal?

Newby D, Hill S. Newby D, et al. J Clin Pharm Ther. 2003 Apr;28(2):145-50. doi: 10.1046/j.1365-2710.2003.00455.x. J Clin Pharm Ther. 2003. PMID: 12713612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters